Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST).
Hongjo ChoiJeong Ha MokYoung Ae KangDawoon JeongHee-Yeon KangHee Jin KimHee-Sun KimDoo Soo JeonPublished in: Journal of Korean medical science (2023)
The treatment outcomes of patients with MDR/RR-TB has gradually improved but increasing deaths during treatment is an emerging challenge for MDR-TB control in Korea. Targeted and comprehensive care is needed for vulnerable patients such as the elderly, patients with comorbidities, and those with low household incomes.
Keyphrases
- mycobacterium tuberculosis
- end stage renal disease
- multidrug resistant
- newly diagnosed
- healthcare
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- palliative care
- emergency department
- pulmonary tuberculosis
- cancer therapy
- middle aged
- cross sectional
- patient reported outcomes
- drug delivery
- hiv aids
- health insurance
- patient reported
- adverse drug